Anthropic has introduced Claude Fable 5, its first publicly available Mythos-class AI model, marking a major step in expanding access to technology that was previously restricted to a small group of trusted organizations. The company says Fable 5's capabilities exceed those of earlier publicly released Claude systems, particularly in software engineering, complex reasoning, knowledge work, and vision tasks, across demanding workflows.

The new model is based on the same foundation as Claude Mythos 5, a system Anthropic previously considered too powerful for broad release. To make public deployment possible, the company added targeted safeguards that monitor sensitive requests. When users enter prompts involving cybersecurity, biology, chemistry, or model distillation, the system can redirect responses to Claude Opus 4.8, a restricted model.

Notable enhancements include stronger long-context performance, improved autonomy, advanced visual understanding, and better scientific research capabilities. Anthropic reports that Fable 5's advantage grows as tasks become longer and more complex. The company highlighted results in coding, analytics, finance, and research evaluations, where the model demonstrated higher accuracy, efficiency, and problem-solving ability than previous public Claude releases to date.

Anthropic believes the launch could expand access to frontier AI while reducing risks associated with misuse. The release reflects a broader industry trend toward balancing capability gains with safety controls. Rather than withholding advanced systems, developers are increasingly exploring controlled deployment strategies that allow wider adoption without exposing the most sensitive capabilities to unrestricted public use today.

Alongside Fable, Anthropic also introduced Claude Mythos 5, a less restricted version available to selected partners through trusted access programs. Fable 5, however, is the company’s primary public offering and is available immediately through supported Claude plans and platforms. The launch underscores Anthropic’s effort to deliver cutting-edge AI capabilities more broadly while maintaining safeguards around higher-risk applications.

Source: Anthropic

Robi’s Insights:

OpenAI Brings Interactive Charts to ChatGPT: OpenAI has launched interactive charts in ChatGPT, enabling users to generate and explore in-line graphs directly from data within their conversations.

Source: XPost

Industry observers see the price cut as more than a simple promotional offer. According to investors and analysts cited by TechCrunch, the move signals the beginning of a broader AI subscription price war in the U.S. market. Google’s massive infrastructure, distribution network, and ability to bundle services give it significant advantages over standalone AI companies.

The strategy mirrors developments already seen in emerging markets such as India, where both Google and OpenAI introduced lower-cost AI plans to attract new users. Analysts believe the growing competition could place pressure on companies like OpenAI and Anthropic to reconsider pricing models as AI services become increasingly commoditized and customer acquisition becomes the primary battleground.

Source: Tech Crunch

Meta Launches Workforce Academy to Train Data Center : is investing $115 million in a free five-week Workforce Academy that trains workers for data center construction jobs and guarantees employment upon graduation as the company accelerates its AI infrastructure expansion.

Source: WSJ

A new report from the Medical Protection Society warns that doctors and the NHS could face negligence claims when artificial intelligence systems contribute to diagnostic or treatment errors. The warning highlights a growing legal gap as healthcare organizations increasingly adopt AI tools to support clinical decision making and administrative tasks.

According to the report, current UK liability rules may leave clinicians responsible even when an AI application makes the underlying mistake. Examples include software missing a tumor on an Xray or generating an incorrect medication recommendation. In those circumstances,

The organization argues that clinicians risk becoming a liability sink unless legislation is updated. It recommends classifying AI systems as products under the Consumer Protection Act, creating clearer pathways for accountability among developers, manufacturers, healthcare institutions, and users. Healthcare leaders have also stressed that transparent governance oversight and legal clarity are essential as AI becomes more deeply embedded across diagnostics documentation triage and other clinical workflows.

While the report does not oppose the use of AI in medicine it emphasizes that innovation should be matched by safeguards that protect patients and clinicians alike. Future policy discussions will likely focus on balancing technological benefits with responsibility ensuring that those who design build deploy and oversee AI share appropriate legal responsibility.

Source: The Guardian

AI Tool You Did Not Know You Needed

Can you outsmart AI?

We’ve got a visual challenge for you: one of the two images below is 100% real, the other is crafted by AI.

Click option below A or B. 👇

Ready to take your AI journey further?

Craving more AI chaos?

Read Daily AI News at BitBiased.AI. Support us by following us on LinkedIn and X ( Twitter ).

Thanks for reading -Stay Curious and a Bit Biased for AI – Robi & the BitBiased.AI team